Breaking News

Lilly Sells API Site to Evonik

Lilly has sold its Tippecanoe Laboratories manufacturing facility to Evonik Industries AG

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lilly has sold its Tippecanoe Laboratories manufacturing facility to Evonik Industries AG. The manufacturing site, located in Lafayette, IN, will remain in operation with a focus on producing high-quality APIs and specialty chemical and animal health products. The two companies will also enter into a nine-year supply and services agreement, in which Evonik will manufacture final and intermediate step APIs for certain Lilly human and animal health products. Approximately 700 current Lilly emp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters